These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 28954975

  • 21. Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.
    Yang H, Sun C, Ye L, Xu Y, Lin S, Peng Q, Wang G, Lu X.
    Arthritis Res Ther; 2024 Sep 11; 26(1):158. PubMed ID: 39261921
    [Abstract] [Full Text] [Related]

  • 22. Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.
    Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W.
    Neurology; 2018 Feb 06; 90(6):e507-e517. PubMed ID: 29330311
    [Abstract] [Full Text] [Related]

  • 23. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.
    Musset L, Miyara M, Benveniste O, Charuel JL, Shikhman A, Boyer O, Fowler R, Mammen A, Phillips J, Mahler M.
    J Immunol Res; 2014 Feb 06; 2014():405956. PubMed ID: 24741598
    [Abstract] [Full Text] [Related]

  • 24. Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.
    Anquetil C, Boyer O, Wesner N, Benveniste O, Allenbach Y.
    Autoimmun Rev; 2019 Mar 06; 18(3):223-230. PubMed ID: 30639649
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.
    Autoimmun Rev; 2016 Oct 06; 15(10):983-93. PubMed ID: 27491568
    [Abstract] [Full Text] [Related]

  • 27. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I, Mammen AL.
    Curr Opin Rheumatol; 2016 Nov 06; 28(6):619-24. PubMed ID: 27607340
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV.
    Scand J Rheumatol; 2020 Sep 06; 49(5):405-411. PubMed ID: 31801390
    [Abstract] [Full Text] [Related]

  • 30. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J, Sanmaneechai O, Charuvanij S, Sangruchi T, Galindo-Feria AS, Lundberg IE, Ohnuki Y, Shiina T, Suzuki S, Nishino I.
    Neuromuscul Disord; 2019 Jul 06; 29(7):543-548. PubMed ID: 31204143
    [Abstract] [Full Text] [Related]

  • 31. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
    Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M.
    JAMA Neurol; 2015 Sep 06; 72(9):996-1003. PubMed ID: 26192196
    [Abstract] [Full Text] [Related]

  • 32. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
    Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L.
    Ann Rheum Dis; 2017 Apr 06; 76(4):681-687. PubMed ID: 27651398
    [Abstract] [Full Text] [Related]

  • 33. Alanine transaminase is predominantly increased in the active phase of anti-HMGCR myopathy.
    Kubota A, Shimizu J, Unuma A, Maeda M, Shirota Y, Kadoya M, Uchio N, Sakiyama Y, Arai N, Shiio Y, Uesaka Y, Hashida H, Iwata NK, Goto J, Nakashima R, Mimori T, Toda T.
    Neuromuscul Disord; 2022 Jan 06; 32(1):25-32. PubMed ID: 34916121
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Anti-HMGCR Antibody-Positive Myopathy Shows Bcl-2-Positive Inflammation and Lymphocytic Accumulations.
    Kurashige T, Murao T, Mine N, Sugiura T, Inazuka Y, Kuraoka K, Takahashi T, Maruyama H, Torii T.
    J Neuropathol Exp Neurol; 2020 Apr 01; 79(4):448-457. PubMed ID: 32100014
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Immune-Mediated Necrotizing Myopathy].
    Uruha A.
    Brain Nerve; 2024 May 01; 76(5):646-654. PubMed ID: 38741508
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L, Arouche-Delaperche L, Allenbach Y, Benveniste O.
    Curr Rheumatol Rep; 2018 Aug 03; 20(9):56. PubMed ID: 30074107
    [Abstract] [Full Text] [Related]

  • 40. [Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases].
    Marti J, Kolev I, Lorleac'h A, Besnard S, Pihan M, Marcorelles P.
    Rev Med Interne; 2017 Apr 03; 38(4):228-234. PubMed ID: 27876175
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.